Biology subjects

Montefusco, S.

Publications and source records attributed to Montefusco, S..

4 recordsLinked to original sources

bioRxiv2026

Ion Mobility-Guided Tandem Mass Spectrometry Imaging Resolves Bis(monoacylglycero)phosphate and Phosphatidylglycerol Isomers in Tissue

Molecular specificity remains a major challenge in mass spectrometry imaging (MSI), particularly when low-abundance species coexist with structurally related isomers that cannot be distinguished by accurate mass and exhibit similar fragmentation behavior. Bis(monoacylglycero)phosphates (BMPs), lysosomal lipids increasingly implicated in lipid homeostasis and disease, represent a particularly demanding example because they are structural isomers of phosphatidylglycerols (PGs) and display highly similar negative-ion fragmentation. Here, we developed an ion mobility-guided targeted MALDI-MS/MS imaging workflow for direct on-tissue discrimination of endogenous BMP/PG isomeric pairs. Orthogonal HILIC-DDA-PASEF analysis provided accurate-mass, retention-time, fragmentation, and ion-mobility information used to define mobility-constrained precursor coordinates for scheduled MALDI-iPRM-PASEF acquisition. Ion-mobility measurements showed high agreement across ESI-TIMS, MALDI-TIMS, and tissue-based MALDI-TIMS-MSI, while optimization of laser sampling minimized ion-load-dependent mobility shifts. Narrow mobility windows reduced reciprocal PG/BMP cross-talk to below 4% while preserving selective detection under strongly unbalanced abundance conditions. The workflow enabled distinct precursor- and product-ion imaging of endogenous PG 34:1 and BMP 34:1 in sagittal mouse brain, supporting their acyl-chain-level assignment as PG 16:0_18:1 and BMP 16:0_18:1. Application to a CLN3-knockout mouse model revealed BMP-specific reductions across brain, kidney, and lung that were not mirrored by the corresponding PG isomers, providing an orthogonal biological validation of the analytical discrimination. Mobility-constrained targeted MS/MS additionally resolved type-II isotopic interference that remained ambiguous at the MS1 level. Overall, this work provides a strategy for reciprocal spatial discrimination and structural confirmation of endogenous BMP and PG isomers directly in tissue and highlights the value of combining ion mobility with targeted product-ion imaging to increase molecular specificity in spatial lipidomics.

biochemistry↗

bioRxiv2026

Label-Free Nucleoli Measurement by 3D Holo-Tomographic Flow Cytometry Using Biolens Phase Compensation

Holo-Tomographic Flow Cytometry (HTFC) holds the potential to transform cellular research and clinical screening through 3D label-free quantitative phase imaging (QPI) of flowing single cells. However, it has been limited by insufficient intracellular specificity in 3D refractive index (RI) distributions, since suspended cells act as highly aberrating spherical biolenses obscuring internal structures. Here, we show the Biolens Phase Compensation (BPC), a method that corrects phase aberrations in 2D QPI projections to transform the 3D RI tomogram. Working within this new 3D pseudo-RI space demonstrates for the first time the extraction of nucleoli in HTFC. Extensive validation against 2D fluorescence flow cytometry and 3D confocal microscopy demonstrates that BPC achieves reliable intranuclear specificity. Using statistically significant single-cell analysis, we provide multiplexed quantitative 3D measurements of nested intracellular compartments (cytoplasm, nucleoplasm, nucleoli). This approach extends label-free HTFC toward capabilities of gold-standard Fluorescence Microscopy, overcoming its well-known drawbacks in intracellular and intranuclear staining.

biophysics↗

bioRxiv2025

Quantitative profiling of lysosomal accumulation through label-free biomarkers via High-Content Holo-Tomographic Flow Cytometry

Lysosomal storage diseases (LSDs) are genetic disorders caused by enzyme deficiencies that lead to lysosomal dysfunction and progressive cell damage. Accurate visualization and quantification of lysosomes are essential for understanding disease progression and developing effective therapies. Here, for the first time, we successfully identified and characterized lysosomes using an innovative Holo-Tomographic Flow Cytometry (HTFC) technique, which allows label-free, high-content, and high-throughput 3D imaging of lysosomal compartments in single live cells. This breakthrough could revolutionize traditional gold-standard methods overcoming the actual limitations. Leveraging this technology, we discovered novel biomarkers of lysosomal accumulation in LSD-affected cells. In fact, by generating refractive index tomograms, we achieved accurate measurement and comprehensive 3D visualization of cytoplasmic lysosomal aggregation in suspended single cells. Through experimental validation and advanced computational analyses, we identified a quantitative correlation between the 3D lysosomal architecture and the efficacy of various therapeutic strategies, including genetic and pharmacological interventions. This work represents a significant advance in lysosomal research, paving the way for improved diagnostics and the development of targeted therapies for LSDs.

cell biology↗

bioRxiv2024

PAK6 promotes neuronal autophagy by regulating TFEB nuclear translocation.

Autophagy is a highly conserved homeostatic process essential for the bulk degradation of cytoplasmic components and aggregated proteins. Multiple evidence indicates that impairment of (macro)autophagy leads to neurodegeneration, such as Parkinson disease (PD). Our previous work showed that p21 activated kinase 6 (PAK6) interacts with the PD-associated leucine-rich repeat kinase (LRRK2) to promote neurite outgrowth in the mouse striatum; still the function of PAK6 in the brain is largely unknown. Here, we found that downregulation of neuronal but not glial mbt, the D. melanogaster homolog of PAK6, impairs autophagy-lysosomal function. PAK6 overexpression in cells and in C. elegans increases transcription factor EB (TFEB) nuclear translocation in a kinase activity-dependent manner. Mechanistically, PAK6 forms a complex with TFEB to regulate its nuclear localization in a manner dependent on phosphorylation of and binding to 14-3-3 proteins and phosphorylation of TFEB at S467. In line with its ability to promote neuronal autophagy, mbt downregulation exacerbates alpha-synuclein toxicity in Drosophila dopaminergic neurons. Moreover, PAK6 overexpression in the substantia nigra of mutant LRRK2 mice reduces the burden of phosphorylated alpha-synuclein in dopaminergic neurons. Altogether, our study uncovers a novel role of PAK6 as a positive regulator of autophagy via TFEB and suggests that modulating its activity may represent a way to selectively turn on autophagy in neurons, with implications for the treatment of neurodegenerative disorders.

neuroscience↗